7881.Two
7881.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
Business. 7881.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7881.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, generating revenue primarily through the sale and distribution of medical products.
The company's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.94, suggesting that the company's current liabilities slightly exceed its current assets. The company's free cash flow of 54,897,000 TWD supports its operational flexibility, although its capital expenditure of -62,723,000 TWD indicates a net outflow from investing activities.
In terms of profitability, the company's return on equity of 28.19% and return on assets of 7.6% are strong indicators of efficient use of equity and assets to generate profit. These metrics suggest that the company is performing well relative to industry standards, although specific comparisons to cohort medians are not available in the provided data.
The company's revenue concentration is not explicitly detailed in the provided data, but the absence of segment or geographic breakdowns implies that the company may have a relatively undiversified revenue stream. This could pose a risk if the company's primary market experiences a downturn.
The company's growth trajectory is not explicitly outlined in the provided data, but the absence of specific revenue growth figures or outlooks suggests that the company may be in a stable or maintenance phase. The company's operating income of 66,344,000 TWD and net income of 52,293,000 TWD indicate a healthy profit margin, which could support future growth initiatives.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to avoid liquidity constraints. The company's dilution potential is low, which is a positive sign for shareholders.
Recent events and filings are not detailed in the provided data, but the company's financial snapshot indicates a stable financial position with a strong gross profit margin of 261,117,000 TWD. The company's total assets of 688,165,000 TWD and total liabilities of 502,668,000 TWD suggest a solid balance sheet, although the company's long-term debt of 113,555,000 TWD should be monitored for potential refinancing needs.
- The company has a strong return on equity of 28.19%, indicating efficient use of equity to generate profit.
- The company's liquidity position is medium, with a current ratio of 0.94, suggesting that current liabilities slightly exceed current assets.
- The company's debt-to-equity ratio of 0.61 indicates a moderate reliance on debt financing.
- The company's free cash flow of 54,897,000 TWD supports operational flexibility.
- The company's dilution risk is low, which is a positive sign for shareholders.
- **margin_outlook_rationale**: The company's strong gross profit margin suggests that it can maintain or improve its profitability outlook.
- **rd_outlook_rationale**: The company's financial snapshot does not provide specific R&D figures, but the absence of negative indicators suggests a stable R&D outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7881.TWO Market data — financials · 2026-05-27